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Adaptive immune responses associated with allergic reactions recognize antigens from a broad spectrum of plants and animals.
Herein a meta-analysis was performed on allergy-related data from the immune epitope database (IEDB) to provide a current
inventory and highlight knowledge gaps and areas for future work. The analysis identiﬁed over 4,500 allergy-related epitopes
derived from 270 diﬀerent allergens. Overall, the distribution of the data followed expectations based on the nature of allergic
responses. Namely, the majority of epitopes were deﬁned for B cells/antibodies and IgE-mediated reactivity, and relatively fewer
T-cell epitopes, mostly CD4+/class II. Interestingly, the majority of food allergen epitopes were B-cells epitopes whereas a fairly
even number of B- and T-cell epitopes were deﬁned for airborne allergens. In addition, epitopes from nonhumans hosts were
mostly T-cell epitopes. Overall, coverage of known allergens is sparse with data available for only ∼17% of all allergens listed by
the IUIS database. Thus, further research would be required to provide a more balanced representation across diﬀerent allergen
categories. Furthermore, inclusion of nonpeptidic epitopes in the IEDB also allows for inventory and analysis of immunological
data associated with drug and contact allergen epitopes. Finally, our analysis also underscores that only a handful of epitopes have
thus far been investigated for their immunotherapeutic potential.
1.Introduction
It is estimated that 50 million people in the US are aﬀected
by airborne allergens, including approximately 35 million
aﬀected by upper respiratory allergies (allergic rhinitis, hay
fever and pollinosis) [1], and 16 million aﬀected by asthma
[2, 3]. The cost of allergies in the US (treatment and loss
of work) is estimated to be more than $18billion per year
[4]. Food allergies, representing the second largest category
after respiratory allergies, are thought to aﬀect 6–8% of
children and nearly 4% of adults. In the US, there are
∼30,000 episodes of food-induced anaphylaxis, associated
with 100–200 deaths per year [5, 6]. Finally, skin contact
allergies and allergies to insect venoms also occur with
signiﬁcant incidence and are thus important component of
allergic diseases in humans. These ﬁgures underscore the
growing societal impact of allergy-related disease both in
terms of human suﬀering as well as annual cost burden.
The immunological basis of allergy-related disease is
universally recognized. At the level of adaptive immunity,
the recognition of speciﬁc allergens by antibodies and T
cells plays major roles both as eﬀectors and regulators of
allergic diseases. Several bioinformatics resources, cataloging
anddescribingallergenproteinsequences,areavailabletothe
scientiﬁc community such as the Allergome,w h i c hp r o v i d e s
information on allergenic molecules causing IgE-mediated
disease, and Allergen.org, which is the oﬃcial site for the
systematic allergen nomenclature approved by the World2 Journal of Allergy
Health Organization and International Union of Immuno-
logical Societies (WHO/IUIS) Allergen Nomenclature Sub-
committee]. However, until recently, a resource describing
the actual epitopes (deﬁned as the molecular structures
coming in contact with antibodies or T-cell receptors), and
theimmunologicaleventsassociatewithepitoperecognition,
was not available.
The immune epitope database (IEDB) was created, to
provide the scientiﬁc community with a repository of freely
accessible immune epitope data (http://www.immuneepi-
tope.org/). It contains data curated from published litera-
ture, -submitted by the NIAID’s high-throughput epitope
discovery projects, and imported from other databases. The
database contains antibody and T-cell data for human,
nonhuman primate, and rodent hosts, as well as a number
of other animal species, and targets epitopes associated
with infectious diseases, autoimmunity, transplantation, and
allergy. Data related to both peptidic and non-peptidic
epitopes are curated within the IEDB.
Recently, curation of allergy-related references was com-
pleted, and as a result, close to 10,000 records, capturing
4,800 diﬀerent epitopes, and the biological assays associated
with their recognition have become available within the
IEDB. By analogy with what was done in the case of
epitopes associated with inﬂuenza, tuberculosis, malaria,
and other diseases [7–9], herein we report the results of
an in-depth analysis of all published immune epitope data
related to Allergy. This analysis provides an inventory of
epitope structures and associated data in order to enhance
basic research and facilitate the development of therapeutics,
as well as diagnostics. The analysis also identiﬁed certain
knowledge gaps and points to potential areas for future
study.
2. Methods
2.1. Data Inclusion Criteria. This analysis includes data
for antibody and T-cell epitopes associated with allergic
disease in human and nonhuman (animal models) hosts. To
identify within the IEDB the subset of data which is allergy
related, we followed the process described in more detail
by Davies et al. [10]. More speciﬁcally, we deﬁne herein
allergy-related data on the basis of the source from which
the epitope is derived (known allergen), and also on the
basis of the type of response and/or clinical presentation.
Accordingly, we included IgE-mediated, type I (immediate)
hypersensitivity, atopic, “allergen-sensitization,” exposure-
based asthma, allergic rhinitis, pollinosis, contact dermatitis,
atopic dermatitis, documented anaphylaxis, and all data
from allergy-related animal models.
The allergy-related epitopes represent both peptidic as
well as non-peptidic structures from a wide range of sources,
including pollens,dustmites,molds,danderandfoods,non-
p r o t e i nm o i e t i e so fp l a n t s( c a r b o h y d r a t e s ) ,a sw e l la sd r u g s ,
haptens, metals, and chemical substances from occupational
exposures. The curated data was obtained using a variety of
diﬀerent assays, such as ELISA, Western blot, proliferation
assays, surface plasmon resonance (SPR), radio immunoas-
say (RIA), and X-ray crystallography, and describes epitope-
related reactivity such as histamine release, hypersensitivity
(PCA), delayed-type hypersensitivity (DTH), and immun-
otherapy assays.
All of the data described herein were captured directly
from the peer-reviewed literature (PubMed) by Ph.D. level
scientists or through direct submission to the IEDB by
research groups. Antibody and T-cell epitope deﬁnitions
(length and mass restrictions) as well as IEDB inclusion cri-
teria can be found at http://tools.immuneepitope.org/wiki/
index.php/Main Page. For the purpose of this report, the
total number of epitopes reported in each case represents the
total number of unique molecular structures experimentally
shown to react with a B- cell or T-cell receptor (no
predictions included). The IEDB captures these structures
as they are deﬁned in the literature and thus includes
data describing structures categorized as minimal/optimal
epitopes (11–15 resides), larger less well-deﬁned regions
(20–50 residues), and key residues identiﬁed as being
involved in binding (1-2 residues).
2.2. Analysis Approach. The entirety of the allergy-related
data identiﬁed as described above was ﬁrst inventoried to
identify the total number of structures (positive and negative
epitopes), their chemical nature (peptidic or non-peptidic),
the total number of antibody/B-cell versus T-cell epitopes,
as well as the eﬀector cell phenotype or antibody isotype,
and ﬁnally the total number of peer-reviewed references
from which the data were derived. The second step involved
investigating the distribution of epitopes among hosts: those
epitopes deﬁned in humans versus those identiﬁed using
nonhuman animal models of allergy. In each case, the
inventory of epitopes per host species included a breakdown
according to reactivity: B cell (linear or conformational) or T
cell (CD4, CD8 or unspeciﬁed).
Following the initial inventory, the data were categorized
according to the following established allergy categories:
food, airborne (respiratory), contact, drug, and allergies to
biting insects. This categorization was based on the allergen
and genus species of the organism from which the epitope
was derived. These main categories were then further parsed
into subcategories on the basis of taxonomic origins (plant,
animal or fungus) and included a subcategory for the most
commonly encountered species in that main category.
The individual compounds representing drugs/pharma-
ceuticals were parsed into 21 subcategories on the basis of
its chemical type (e.g., beta-lactam antibiotic) or by the way
the compound is used to treat a particular condition (e.g.,
muscle relaxant). Contact allergen data were also further
parsed into subcategories based on their species of origin
(plants), chemical type (metals, model haptens), or mode of
exposure (chemical agents from occupational exposure).
2.3. Computational Methods. The allergy-related data extra-
cted from the IEDB (http://www.immuneepitope.org/)w a s
stored in a MySQL database. The use of MySQL allows for
the tailoring of database schema to the speciﬁc analysis and
to keep the data synchronized with updates of the IEDB dataJournal of Allergy 3
Table 1: Overview of allergy epitope data included in the IEDB.
Category Total number
References 678
Epitopes (positive structures) 4,800
Negative structures 4,137
Antibody/B cell 3,194
Linear natural peptides 2,730
Linear analogs/no natural source 163
Discontinuous determinants 65
T cell 1,646
CD4+/Class II 1,530
CD8+/Class I 17
Unspeciﬁed 99
Unique allergens (peptidic/nonpeptidic) 550
Source species 88
Food allergy epitopes 2,322 (53%)
Airborne allergy epitopes 1,750 (40%)
Stinging insects epitopes 127 (3%)
Drug allergy epitopes 106 (∼2%)
Contact allergy epitopes 82 (∼2%)
Table 2: Antibody isotype associated with epitope reactivity.
Antibody isotypes Number of reactive epitopes
Overall Human Nonhuman
Allergy-speciﬁc IgE 2,205 2,135 70
Other antibody reactivity
IgG, unspeciﬁed 495 192 303
IgG1 132 0 132
IgG4 72 72 0
IgM 50 32 18
IgG2b 10 0 10
IgA 5 0 5
IgG3 5 2 3
IgG2a 2 0 2
IgG2c 1 0 1
production database. Data were periodically checked against
the IEDB webpage using simple or advanced query interfaces
for consistency and accuracy. Results from each query
were exported as Excel ﬁles and further analyzed in that
format. Tables and ﬁgures were generated from Excel. Data
exclusions included structures for which only MHC binding
data were available, as well as those instances in which the
epitope was simultaneously used as both immunogen and
assay antigen.
3. Results
3.1. Data Overview. An overview of all allergy-related data
captured by our analysis is provided in Tables 1 and 2.
Consistent with the importance of immunoglobulin-related
responses as eﬀectors of allergy responses, the majority of
epitopes (both peptidic and non-peptidic) were deﬁned
for antibody responses, including both linear (∼3,000) and
conformational (or discontinuous) determinants (peptidic
only) (Table 1). A total of 2,205 IgE epitopes were reported
for all allergens, and less numerous other reactivities related
to total IgG followed distantly by IgG1 IgG4, IgM, IgA,
IgG2b, IgG3, IgG2a, and IgG2c (Table 2). As can be seen,
the majority of antibody determinants were deﬁned in
humans. In animal models of disease, not only relatively
fewer epitopes were deﬁned, but only about 10% of them
are epitopes recognized by IgE. This highlights a crucial
knowledge gap and suggests that more research could be
directed at the deﬁnition of the epitopes recognized by IgE
in animal models of allergy.
A relatively smaller number of T-cell epitopes have
been identiﬁed (1,646 epitopes) (Table 1). Of the T-cell
epitopesdeﬁnedinbothpeptidicandnon-peptidicallergens,
CD4+/Class II epitopes were most numerous, and far fewer
CD8+/Class I epitopes were reported. Given their potential
role in contact dermatitis and other delayed-type hypersen-
sitivity reactions, it is likely that more eﬀort could be devoted
to the deﬁnition of class I epitopes. Supplementary Figure 1
(see Figure s1 in supplementary material available on line at
doi: 10.1155/2007/628026) provides a response summary for
all epitope data.
ThehostdistributionofepitopescanbefoundinTable 3.
Not surprisingly, the vast majority of epitopes were deﬁned
in humans. However, epitopes were also described for mon-
keys, pigs, dogs, rabbits, guinea pigs, rats, and mice. Of the
nonhuman species, epitopes deﬁned in mice represented the
second largest group. Within epitopes deﬁned in mice, more
than 30 diﬀerent strains were represented (data not shown).
BALB/c predominated, followed distantly by C57BL/6 and
C3H/He. Data from human HLA transgenic strains (HLA-A,
DR4, DQ6, DQ8, and DR3-DQ2) were also reported. Table 1
also describes a breakdown of epitope numbers categorized
as related to food allergies, airborne or respiratory allergies,
allergies to stinging insects, drug allergies, and contact
allergies. Food allergens represent by far the largest group
of data in the IEDB. There are currently 2,322 (53%) B-
and T-cell epitopes identiﬁed from this group. After food
allergens, epitopes deﬁned for aeroallergens represent the
second largest group, accounting for 40% of the records. To
date, the database contains 125 antibody and T-cell epitopes
related to the venom of stinging insects, which make up
3% of the epitope total. Drug allergies account for ∼2%
of epitopes. Contact allergies manifested through the skin
account for ∼2% of allergy epitopes. The following sections
describe each epitope category in more detail.
3.2. Food Allergies. These include both peptidic and non-
peptidic determinants derived fromboth plantsand animals.
The data have been parsed into three broad categories;
most common food allergen sources, other plant, and other
animal species (Table 4). Peanut (Arachis hypogaea)a l l e r g e n s
which comprise nearly 40% of the total plant allergen
epitopes. Epitopes described for food allergens derived from
animals fall into six taxonomic categories. These include
mammals (human and cow milk, beef, beef gelatin), bony4 Journal of Allergy
Table 3: Host distribution for peptidic and non-peptidic epitopes.
Allergic host All T cell CD4, class II CD8, class I All B cell Linear B cell Nonlinear Overall
Peptidic epitopes
Human 1,483 1,406 9 2,590 2,541 49 4,073
Animal models
Japanese macaque 0 0 0 2 2 0 2
Pig 0 0 0 5 5 0 5
Dog 23 23 0 0 0 0 23
Rabbit 0 0 0 337 337 0 337
Rat 1 1 0 6 6 0 7
Mouse 304 271 6 388 357 31 692
Nonpeptidic epitopes
Human 50 42 1 72 — — 122
Animal models
Rabbit 0 0 0 36 — — 36
Guinea pig 8 0 0 12 — — 20
Rat 2 1 0 2 — — 4
Mouse 26 5 2 50 — — 76
ﬁsh(cod),bird(chickeneggs),mollusks(abaloneandsnails),
crustaceans (shrimp and prawns), and nematodes (ﬁsh meat
parasite). By far, the largest number of epitopes has been
identiﬁed for allergens related to cow’s milk allergy, followed
by epitopes deﬁned from eggs, representing 70% and 20% of
the total, respectively. Non-peptidic food epitopes reported
todatearecomprisedofcarbohydratesderivedfrompeanuts,
sugar beets, celery, and sea squirt (see also supplemental
Table 6).
According to the CDC [11], allergens derived from
milk, eggs, peanuts, tree nuts, ﬁsh, shellﬁsh, soy, and wheat
account for 90% of all food allergies. The epitope data in
general reﬂect this distribution. However, fewer epitopes
were identiﬁed from ﬁsh (only 10 epitopes for one species)
and shellﬁsh other than shrimp. Conversely, there was a
surprisingnumberofepitopesdescribedfromfruitallergens,
namely peaches, apples, and bananas. This observation may
reﬂect the involvement of these species in the oral allergy
syndrome (OAS) or pollen-food allergy and cross-reactions
between foods (fruits, nuts) and inhaled allergens [12–15].
3.3. Airborne Allergies. Epitopes deﬁned for aeroallergens
representthesecondlargestgroupwithintheIEDB,account-
ing for 40% of the records, including peptidic and non-
peptidic determinants derived from plants, animals, fungal
allergens, and some industrial chemical agents. Here, the
data was parsed into the categories of most common
airborne sources, other plant, fungal, and animal species
(Table 5). Epitopes identiﬁed from pellitory pollen, as well as
those from birch and Japanese cedar pollen, are numerous.
Epitopes reported for grass pollens come primarily from
Timothy grass, ryegrass species, and Kentucky blue grass.
In the taxonomic grouping representing fungi, which
includes yeasts and molds, epitopes identiﬁed in antigens
from Aspergillus species dominate (70%). Finally, epitopes
derived from aeroallergens from animals fall into three
broad taxonomic categories: insects (cockroach and midge),
arachnids (house dust mite, Storage mite, and Fodder mite),
and mammals (cat, dog, horse, cow, rat, and mouse). Among
the insects, epitopes derived from the midge are the most
numerous, and within the Arachnid class, European house
dust mites are the most heavily studied.
Three non-peptidic determinants were described (see
supplemental Table 6). These included α-L-Fuc-(1->3)-[α-
D-Man-(1->3)-[α-D-Man-(1->6)]-[β-D-Xyl-(1->2)]-β-D-
Man-(1->4)-β-D-GlcNAc-(1->4)]-D-GlcNAc from cedar
pollen, D-glucopyranuronic acid from the fungus Trichospo-
ron cutaneum, and mono-β-arabinofuranose from mugwort
pollen. In addition, a number of non-peptidic chemicals
were identiﬁed, including compounds causing respiratory
symptoms following occupational exposure; toluene 2,4-di-
isocyanate (TDI), toluene meta-diisocyanate, 4-tolyl isocy-
anate, diphenylmethane-4,4 -diisocyanate, hexameth-ylene
diisocyanate, phenyl isocyanate, phthalic anhydride, and
trimellityl group (data not shown).
Here again, the epitope data reﬂects the overall trends
related to airborne allergy. Grass, tree, and weed pollen
epitopes represent the majority of the data (∼60%), followed
by pet dander and house dust mite allergens. These ﬁndings
are consistent with the overall prevalence of hay fever and/or
allergic rhinitis in the general population, aﬀecting some 18
millionpeopleannually[16].Perhapssomewhatunexpected,
was the fairly low number of epitopes deﬁned for cat
allergens.Interestingly,themajorityoffoodallergenepitopes
were B-cells epitopes (86%) whereas a fairly even number of
B (43%) and T-cell (57%) epitopes were deﬁned for airborne
allergens (data not shown).
3.4. Allergies to Stinging Insects. To date, the IEDB contains
125 antibody and T-cell epitopes related to the venom of
stinging insects (Table 6). These include honeybee (Apis
mellifera), bald-faced hornets (Dolichovespula maculate),Journal of Allergy 5
Table 4: Epitope data related to food allergy. Genus species have been modiﬁed to match IUIS usage. Synonyms for querying the IEDB:
tomato (Solanum lycopersicum) and brown shrimp is (Farfantepenaeus aztecus).
Category All T cell CD4/class
II
CD8/class
I All B cell Linear B
cell
Non-
linear B
cell
Total
epitopes
Common food allergen sources
Cow’s milk (Bos domesticus) 90 90 0 661 659 2 751
Peanut (Arachis hypogaea) 26 26 0 337 337 0 363
Egg (Gallus domesticus) 75 59 1 150 149 1 225
Common wheat (Triticum aestivum) 0 0 0 128 127 1 128
Soybean (Glycine max) 1 1 0 71 71 0 72
Hazelnut (Corylus avellana) 27 27 0 27 27 0 54
Brown shrimp (Penaeus aztecus) 0 0 0 53 53 0 53
Cashew (Anacardium occidentale) 0 0 0 27 27 0 27
Common walnut (Juglans regia) 0 0 0 27 27 0 27
Sesame seed (Sesamum indicum) 0 0 0 11 11 0 11
Baltic cod (Gadus callarias) 0 0 0 10 10 0 10
Brazil nut (Bertholletia excelsa) 0 0 0 7707
Other plant species
Peach (Prunus persica) 43 43 0 15 15 0 58
Banana (Musa acuminata) 1 1 0 51 51 0 52
Buckwheat (Fagopyrum esculentum) 0 0 0 39 39 0 39
Apple (Malus x domestica) 1 1 0 27 24 3 28
Celery (Apium graveolens)1 4 0 0 0 0 0 1 4
Muskmelon (Cucumis melon) 0 0 0 12 12 0 12
Oriental mustard (Brassica juncea) 0 0 0 9909
Rice (Oryza sativa japonica) 0 0 0 5505
American plum (Prunus armeniaca) 0 0 0 4404
European plum (Prunus domestica) 0 0 0 4404
Chinese date (Ziziphus mauritiana) 0 0 0 4404
Sweet cherry (Prunus avium) 1 0 0 3034
Common oat (Avena sativa) 4 4 0 0004
Tomato (Lycopersicum esculentum) 0 0 0 2202
Yellow mustard (Sinapis alba) 0 0 0 2112
Chinese cucumber (Trichosanthes kirilowii) 0 0 0 1101
Goat grass (Aegilops markgraﬁi) 1 1 0 0001
Naked oats (Avena nuda) 1 1 0 0001
Mango (Mangifera indica) 0 0 0 1101
Other animal species
Beef (Bos domesticus) 2 2 0 10 10 0 12
Human breast milk (H. sapiens) 0 0 0 6606
Cow gelatin (Bos domesticus) 0 0 0 3303
Horned turban snail (Turbo cornutus) 0 0 0 2202
Red abalone (Haliotis rufescens) 0 0 0 1011
Fish nematode (Anisakis simplex) 0 0 0 1101
black-bellied hornets (Vespa basalis), common wasps
(Vespula vulgaris), and ants (Myrmecia pilosula). Of these,
epitopes derived from honeybees represent the largest
portion, followed by wasps and bald-faced hornets.
Surprisingly, only 2B-cell epitopes for ant venom,
1B-cell epitope for Black-faced hornets, and no antibody
determinants for wasp venom were deﬁned. There are
also two non-peptidic determinants for antibody reactivity6 Journal of Allergy
Table 5: Epitope data related to Airborne/Respiratory Allergy. Genus species have been modiﬁed to match IUIS usage. Synonyms for
querying the IEDB: Arizona cypress (Hesperocyparis arizonica).
Category All T cell CD4/class
II
CD8/class
I All B cell Linear B
cell
Non-
linear B
cell
Total
epitopes
Common airborne allergen sources
Birch tree (Betula verrucosa) 175 167 0 36 30 6 211
Japanese cedar (Cryptomeria japonica) 181 180 0 19 19 0 200
European house dust mite (D. pteronyssinus) 104 87 2 53 39 14 157
Mold (Aspergillus fumigatus) 16 16 0 115 111 4 131
Timothy grass (Phleum pratense) 72 71 1 49 48 1 121
Perennial ryegrass (Lolium perenne) 69 60 0 36 32 4 105
Midge (Chironomus thummi thummi) 30 30 0 60 60 0 90
O l i v et r e e( Olea europaea)1 4 0 0 6 5 6 5 0 7 9
Cat (Felis catus) 48 46 0 18 18 0 66
Japanese cypress (Chamaecyparis obtusa)6 2 6 0 0 1 1 0 6 3
Spreading pellitory (Parietaria judaica) 1 1 0 61 60 1 62
Kentucky bluegrass (Poa pratensis)1 8 0 0 3 4 3 4 0 5 2
Cereal rye (Secale cereale) 0 0 0 51 51 0 51
Dog (Canis lupus familiaris)5 0 5 0 0 0 0 0 5 0
American house dust mite (D. farinae) 36 36 0 12 9 3 48
Mold (Penicillium chrysogenum) 0 0 0 45 44 1 45
Horse (Equus caballus)4 2 4 2 0 1 0 1 4 3
Bermuda grass (Cynodon dactylon)2 3 2 3 0 3 3 0 2 6
Annual ragweed (Ambrosia artemisiifolia) 12 12 0 13 13 0 25
Other plant species
Common wormwood (Artemisia vulgaris)1 9 1 9 0 0 0 0 1 9
Sunﬂower (Helianthus annuus) 0 0 0 18 18 0 18
Common velvet grass (Holcus lanatus) 0 0 0 14 14 0 14
Ashe juniper tree (Juniperus ashei) 0 0 0 13 13 0 13
Great ragweed (Ambrosia triﬁda) 5 5 0 0005
Loblolly pine tree (Pinus taeda) 0 0 0 4404
Lichwort (Parietaria oﬃcinalis) 0 0 0 2202
Mouse ear cress (Arabidopsis thaliana) 2 2 0 0002
Queen Anne’s Lace (Daucus carota) 1 0 0 0001
Elegant zinnia (Zinnia violacea) 1 1 0 0001
Tobacco (Nicotiana tabacum) 0 0 0 1101
Tall fescue grass (Festuca arundinacea) 0 0 0 1101
Arizona cypress tree (Cupressus arizonica) 0 0 0 1101
Formosan juniper tree (Juniperus formosana)0 0 0 1101
Other fungal species
Alternaria alternata 00 05 5 0 5
Malassezia sympodialis 00 01 0 1 1
Candida albicans 00 01 1 0 1
Paracoccidioides brasiliensis 10 00 0 0 1
Aspergillus restrictus 00 01 1 0 1
Other animal species
Rat (Rattus norvegicus)1 9 0 0 4 4 0 2 3
Storage mite (Blomia tropicalis) 0 0 0 18 16 2 18
Fodder mite (Lepidoglyphus destructor)1 0 1 0 0 5 5 0 1 5
German cockroach (Blattella germanica)9 9 0 5 3 2 1 4Journal of Allergy 7
Table 5: Continued.
Category All T cell CD4/class
II
CD8/class
I All B cell Linear B
cell
Non-
linear B
cell
Total
epitopes
Cow dander (Bos domesticus)8 8 0 2 0 2 1 0
Mayne’s house dust mite (Euroglyphus maynei)1 0 0 0 0 0 0 1 0
American cockroach (Periplaneta americana)0 0 0 9819
Mouse (Mus musculus) 4 2 0 4408
Table 6: Epitope data related to stinging insects.
Allergen source All T cell CD4/class
II
CD8/class
I All B cell Linear B
cell
Non-linear
Bc e l l
Total
epitopes
Allergen source species
Honey bee (Apis mellifera) 4 8 4 70 7 5 25 5
Jack jumper ant (Myrmecia pilosula) 0002202
Black-bellied hornet (Vespa basalis) 0001101
Common wasp (Vespula vulgaris) 3 6 3 60 0 0 03 6
Bald-faced hornet (Dolichovespula maculata) 20 17 0 11 11 0 31
Table 7: Summary of allergen coverage. This table provides a
comparison of the total number of allergens designated by the IUIS
and housed within database Allergen.org that match the allergy-
related species reported in the IEDB.
Allergy category Allergen.org IEDB Percent coverage
Food 86 39 45%
Airborne or Respiratory 184 65 35%
Stinging insects 14 6 43%
Contact 13 5 38%
297 115 39%
to honey bee venom. These include α-1,3-fucose and an
N(4)-[α-L-fucosyl-(1->3)-N-acetyl-4-O-glycosyl-D-glucos-
aminyl]-L-asparagine residue (see supplemental Table 6).
3.5. Drug Allergies. The IEDB currently contains curated
data relating to immunological reactions to more than 90
diﬀerent drugs associated with allergic disease. In most
cases, the authors do not identify the exact reactive moiety
of these non-peptidic chemical entities because the assays
are carried out using the intact drug. These drugs can
be further classiﬁed into 21 categories based primarily on
biological function and structure (Figure 1). These include
beta-lactam antibiotics (the penicillins), barbiturate anes-
thetics, bactericidal/antimicrobial, muscle relaxants, anti-
hypertensive, antiparasitic drugs, neurotransmitters, sulfa-
basedantibiotics,localanesthetics,hormones,antiﬁbrinolyt-
ics, antiemetics, antihistamines, antipsychotics, antitussives,
muscle stimulants, opiates, radiocontrast media, spermi-
cides, and a vasoactive agonist. Antibiotics as a whole
comprise nearly half (49%) of the reported drug allergens,
with the vast majority of which are beta-lactam antibiotics.
3.6. Contact Allergies. Thus far, more than 80 contact
allergens have been captured by the IEDB, as summarized
in Figure 2. Epitopes identiﬁed from latex-allergic indi-
viduals represent the largest number of contact allergen
determinants, making up 59% of the total. A total of
reported207latexepitopesincludebothlinearandnonlinear
a n t i b o d ye p i t o p e s ,a sw e l la sT - c e l le p i t o p e s ,p r i m a r i l yo ft h e
CD4+/class II phenotype.
Three additional categories of contact allergens include
non-peptidic entities such as metals, industrial chemicals
encountered by way of occupational exposure, and model
haptens. A total of seven diﬀerent metals described
as associated with allergic contact dermatitis include
beryllium (beryllium sulfate tetrahydrate, beryllium sulfate),
chromium (chromium trichloride), cobalt (cobalt dichlo-
ride), copper (copper sulfate, copper chloride), nickel (nickel
chloride, nickel sulfate) palladium (palladium chloride), and
zincchloride.Ofthese,nosinglemetalentitystandspredom-
inates,andasagroupmetalscompriseonly7%ofthecontact
allergens. Beryllium, chromium, zinc chloride, and cobalt
are most often encountered in the industrial/manufacturing
setting, whereas nickel, copper, and palladium allergies
are most frequently associated with jewelry. Furthermore,
the IEDB contains curated data relating to more than
70 compounds utilized in the manufacture of cosmetics,
dyes, and certain constituents of manufacturing. A very
large number of curated assays relate to model haptens,
which include skin sensitizers such as trinitrophenyl (TNP),
dinitrophenyl (DNP), 1-ﬂuoro-2,4-dinitrobenzene (DNFB),
and dinitrochlorobenzene (DNCB). These compounds have
beenusedclassicallytodeﬁnemechanismsoftypeIVcontact
hypersensitivity. Of these, DNCB appears to have received
the greatest focus. A detailed list of all contact allergens can
be found in supplemental Table 1.8 Journal of Allergy
10%
6%
6%
3%
3%
2%
Barbiturate anesthetic (12) Bactericidal/antiseptic (7)
Muscle relaxant (7) Anti-hypertensive (4) Anti-parasitic (4)
Neurotransmitter (3) Sulfa-based antibiotic (3) Local anesthetic (2)
Hormone (2) Anti-ﬁbrinolytic (1) Antiemetic (1)
Antihistamine (1) Anti-psychotic (2) Anti-tussive (1)
Muscle stimulant (1) Opiate (1) Radiocontrast media (2)
52% β-lactam
β-lactam antibiotic (64)
2%
2% 2%
2%
2%
3%
1%
1%
1%
1% 1%
1% 1%
1%
Figure 1: Drug allergens by functional category. Determinants identiﬁed under this category have been broadly classiﬁed into 21 groups
according to their overall biological functional. The chart presents these data as percentages with the total number of unique assays in
parentheses.
3.7. Epitope Distribution by Allergen. As a further evaluation,
we determined the relative epitope distribution by allergen
foreachsourcespecies(supplementaryTables2–5).Thetotal
number of epitopes described per allergen varies greatly, and
well-knownallergens(e.g.,Arah1,Betv1,orPhlp1)tended
to have greater numbers of deﬁned epitopes compared to
other allergens from the same organism (e.g., seed storage
protein SSP2, Bet v 2, Bet v 4, Phl p 2, or Phl p 11). Similarly,
the total number of T-cell versus B-cell epitopes varied
greatly, with the vast majority of allergens heavily weighted
toward one or the other phenotype and few having a relative
balance of deﬁned B and T epitopes (data not shown).
Next, we analyzed the extent to which the allergens
comprising the epitope-related data represent all known
allergens,aslistedbytheAllergen.org resource,theoﬃcialsite
for the systematic allergen nomenclature (Linnean system)
thatisapprovedbytheWorldHealthOrganizationandInter-
national Union of Immunological Societies (WHO/IUIS)
Allergen Nomenclature Sub-committee. This site maintains
a list of all currently known (described) allergens derived
from plant, animal, and fungal species. We found that total
number of allergens from which epitope data have been
describedvariesfromoneallergensourcetoanother.Insome
instances, epitope data is comprehensive, showing epitope
data for all allergens identiﬁed by the IUIS list for a given
species (e.g., 9/9 Phl p allergens for timothy grass). However
in other cases, allergen distribution is low, showing only
a few of the known allergens (e.g., 6/29 Der p and Der f
allergens for house dust mite), whereas other species have
intermediate distribution (e.g., 4/6 Lol p allergens from rye
grass) (Table 7). Furthermore, when we compared the total
number of allergens in the IUIS that match the allergy-
related species reported in the IEDB, we ﬁnd that ∼40% of
the IUIS-designated allergens are represented in the epitope
data (115 out of 297). However, for an additional 380
known IUIS allergens, no match could be found between
the species in the IUIS and the species described in the
papers in the scientiﬁc literature describing speciﬁc epitopes.
Many of these include organisms from known genera, but
with as yet nonlisted species, as well as other nomenclature
inconsistencies. These results suggest that more eﬀorts can
be devoted to reconciling the origin of allergen-derived data.
3.8. Epitopes Associated with Clinical Disease or Disease
Models. Isolated epitopes can be utilized to induce or
modulate allergic reactions in animal models. The use
of synthetic epitopes to modulate allergic reactions has
also been proposed and tested in a limited number of
clinical trials [17, 18]. Indeed, the epitopes deﬁned in the
course study of human allergic conditions may enable the
investigation of their potential in the immunotherapeutic
setting.
To inventory which epitopes had been tested in these
settings, we queried for antibody and T-cell epitopes thatJournal of Allergy 9
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Figure 2: Categories of contact allergen epitopes. The chart pro-
vides a broad overview of the contact allergen epitope distribution.
were tested either in vivo for their ability to decrease
allergic reactivity in vivo (as measure by the reduction of
symptoms) and for those that were shown to decrease in
vitro markers of allergic disease. This is done by selecting
all B-cell or T-cell contexts designated in the IEDB as assay
type equals “Reduction of Disease after Treatment” (B cell)
or “Treatment” (T cell). Here, the assay type assigned by
the IEDB indicates the nature of the immune response,
and the details of the type of assay used (lung function,
DTH, PCA, etc.) can be found within the curated data
from the assay comments ﬁeld. Table 8 shows the PubMed
identiﬁcation, epitope name, epitope sequence, the host, the
typeofresponse,andallergymodelclassiﬁcationforpeptidic
epitopesidentiﬁedfromthedataashavingapositiveeﬀecton
disease in vivo or on markers of disease as measured in vitro.
4. Discussion
The analysis presented herein identiﬁed over 4,500 allergy-
related epitopes derived from 270 diﬀerent allergens. Pro-
tein allergens were categorized according to their source
organism, which included plants, animals, insects, parasites,
and fungi. Non-peptidic allergens were categorized into
four groups including drugs and biologicals, industrial
compounds, or those related to occupational exposure,
metals, model haptens, and carbohydrates from plants.
Overall, the distribution of the data follows expectations
based on the nature of adaptive responses involved in allergy.
Namely, the vast majority of allergy epitopes were deﬁned
for B cells/antibodies (and in these records, IgE-mediated
reactivity ﬁgured prominently), and relatively fewer T-cell
epitopes (mostly deﬁned as CD4+/class II, with very few
beingdeﬁnedforCD8+/classI).Likewise,mostoftherecords
relatedtothestudyofallergicreactionsinhumans,andfewer
epitopesdeﬁnedformiceandoccasionalepitopesdeﬁnedfor
other hosts such as monkeys, pigs, dogs, rabbits, guinea pigs,
and rats. The majority of peptidic epitopes were deﬁned for
foods (cow’s milk, wheat, peanuts) and plants (tree and grass
pollens), whilethe majority of non-peptidic epitopes deﬁned
for drugs and biologicals (antibiotics).
Interestingly, the vast majority of food allergen-related
epitopes were described for B-cells, whereas a fairly even
number of B- and T-cell epitopes were deﬁned for airborne
allergens. It is not clear why this is the case but may have
to do with historical analysis of allergies to foods such as
milk, peanuts, and eggs which represent a large portion
of that data. The distribution of epitopes varies greatly
between allergen and species. This observation suggests that
deﬁnition of T-cell epitopes involved in food allergies is
lacking and could be the focus of further experimental
investigations.
Another unexpected ﬁnding of our analysis was that the
epitopes deﬁned in hosts other than humans were mostly T-
cell epitopes, and far fewer antibody epitopes were deﬁned.
While it is surprising that so little of the nonhuman antibody
responses are allergy-speciﬁc IgE; this may point to an
important area for experimental investigation, to provide
investigators with animal models faithfully reproducing
human allergic reactions.
Thecurrentanalysisalsorevealedthatcoverageofknown
human allergen by epitope deﬁnition studies is very sparse.
The overall completeness of the epitope-speciﬁc allergy data
with respect to known allergens on a species basis is about
40%.Furthermore,epitopedataisavailableforonly ∼17%of
all allergens listed by IUIS. For certain species, the majority
(if not all) of the known allergens have epitope-related
data (e.g., timothy grass allergens), while other species have
epitope data from only a small number of known allergens
(e.g., apple).
The recent completion of curation of non-peptidic
allergy-related epitopes in the IEDB allows a ﬁrst time inven-
toryandassessmentofimportantdrugandcontactallergens.
The integration within the IEDB of representation and
search capabilities based on the chemical entity of biological
interest (ChEBI) (http://www.ebi.ac.uk/chebi/) database will
further enable the scientiﬁc community to quickly retrieve
and analyze the immunological data associated with these
important classes of allergens.
Finally, our analysis also inventoried which epitopes have
beenusedtoactivelyinduceallergicdiseaseinanimalmodels
or to modulate disease. Only a handful of epitopes have
been investigated for their immunotherapeutic potential. If
the promising results from human clinical trials were to
be veriﬁed in later phase trails, we anticipate that the data
cataloged within the IEDB might provide a wealth of leads
for therapeutic intervention regimens.
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